Cancer Delirium Hospitalized older patients Delirium is a troubling complication in hospitalized older patients with cancer.
D
elirium is a pathophysiological condition characterized by altered consciousness and inattention, cognitive dysfunction, and disturbed psychomotor behavior. Delirium is a frequent complication among hospitalized older adults. 1 Until recently, delirium has been understood as a transient, potentially reversible condition that resolves with treatment and correction of the underlying etiology. There is growing evidence, however, that delirium is not transient but rather more prolonged.
A significant number of hospitalized older patients have incomplete resolution of delirium at hospital discharge. In samples of hospitalized older medical and surgical patients, delirium symptoms persisted at discharge and for up to 12 months after discharge. 2Y6 Especially when it persists, delirium results in longer hospitalization, institutional placement, rehospitalization, higher costs, impaired recovery, functional and cognitive decline, shorter life expectancy, and increased mortality.
7Y11
In patients who are hospitalized with cancer, the rate of delirium ranges from 14% to 55%. 12Y16 Delirium occurs more frequently in certain cancer patient populations. Almost 75% of patients meet the criteria for delirium after bone marrow transplantion, 17 and up to 90% of patients with advanced cancer develop delirium during their last weeks of life. 18Y20 In a sample of 76 hospitalized older patients with cancer, we found a 57% cumulative rate of delirium. 21 Among patients with cancer, delirium can be related to direct and indirect effects of the cancer and its treatment, adverse effects of symptom management, or unrelated comorbid medical conditions. In most cases, the etiology of delirium is multifactorial. 19, 22, 23 Primary or metastatic brain disease often results in delirium. Other common causes of delirium in cancer patients include the following: drugs, infection, metabolic alterations, dehydration, hypoxia, hypoperfusion, anemia, nutritional impairment, liver dysfunction, and renal dysfunction. 16,19,22Y25 Many causes of delirium in patients with cancer are treatable and correctable. Studies indicate that delirium in patients with cancer is potentially reversible, even in those with advanced disease 14,18Y20,22,25,26 A number of factors including age; overall physical condition; baseline cognitive function; the appropriateness, effectiveness, and timeliness of treatment of the underlying cause; and the management of delirium itself influence the reversibility of delirium. 27 Research on delirium in older patients with cancer is lacking. 28, 29 Because older patients with cancer are particularly vulnerable for delirium, more research is needed to enhance our understanding of delirium patterns and resolution in this group. We need to identify factors associated with delirium resolution and persistence to develop targeted prevention and intervention strategies.
In this article, we report findings from a secondary data analysis in which we examined delirium resolution in a sample of hospitalized older patients with cancer. First, we describe trajectories of delirium resolution in the sample, and then we evaluate differences in patient characteristics, delirium characteristics, and etiologic patterns in patients with and without delirium resolution.
n Methods Data for this secondary analysis were collected in 3 studies of acute confusion in hospitalized older adults. 30 The first study identified patterns of delirium development in a sample of hospitalized older patients. Written informed consent was obtained either from the patient or a primary caregiver if the patient exhibited cognitive impairment. The second study determined the incidence of delirium in hospitalized older patients, and the third study tested pattern-specific interventions to prevent and manage delirium. The last 2 studies were conducted in conjunction with a program to incorporate regular cognitive and functional assessments as part of usual nursing care. Although the purposes of the 3 parent studies differed, they used similar methodologies and common variables. All studies including this secondary analysis were reviewed and approved by the institutional review board.
Sample
The parent studies included 627 participants aged 65 years and older and admitted to general medical units in a tertiary medical center. Patients admitted for terminal care and those with a primary psychiatric diagnosis were not included. Our study 21 examining delirium in hospitalized older patients with cancer included a subset of 76 patients who had cancer as a primary or secondary admitting diagnosis. The sample for this secondary analysis was composed of the 43 hospitalized older patients with cancer who also had prevalent or incident delirium (Figure 1 ). Prevalent delirium was defined as the presence of delirium at the admission assessment, and incident delirium was defined as the development of delirium at any time during the entire hospital stay in patients who were free of delirium at the admission assessment.
Variables and Instruments

DELIRIUM
Delirium was assessed at admission, daily during hospitalization, and at discharge using the NEECHAM confusion scale. 31 The NEECHAM scale was developed for the rapid Figure 1 n Sample schema. Scores on the NEECHAM scale identify 4 levels of confusion or delirium. 31 A score greater than 27 indicates normal function or low risk for confusion or delirium. There is an increased risk for confusion or delirium if the score is between 25 and 26 or greater than 26 and with the presence of one of the following clinical risk markers: respiratory rate greater than 23, use of supplementary oxygen, oxygen saturation less than 91%, serum albumin less than 3.0 g/dL, or report of mental status change. A score between 20 and 24 indicates mild confusion or delirium. A NEECHAM score less than 20 indicates moderate to severe confusion or delirium. In this study, a NEECHAM score less than 24 on admission, during hospitalization, or at discharge indicated the presence of delirium. Patients with a NEECHAM score of 20 to 24 are labeled as having mild delirium, and those with a NEECHAM score less than 20 are labeled as having severe delirium.
Patient Characteristics
Patient characteristics determined at the time of admission included age, ethnicity, sex, education, severity of illness, and functional status. Severity of illness was measured with the Acute Physiology and Chronic Health Evaluation (APACHE II) scale. 33 Scores on the APACHE II range from 0 to 71. An increasing score is associated with greater severity of illness. Functional status was measured by the instrumental activities of daily living (IADL) subscale of the Older Americans Resources and Services Scale. 34 Instrumental activities of daily living scores range from 0 to 14. A lower score indicates greater functional impairment. The items were asked so as to measure performance within the month before hospitalization to eliminate the impact of the acute episode. Hospital length of stay was measured in days from admission to discharge.
Etiologic Risk Patterns at Admission
Patients were screened at admission for key clinical risk markers to identify etiologic patterns of delirium development. Belyea et al 35 identified 5 etiologic patterns using cluster analysis and likelihood ratios of key variables. The 5 etiologic risk patterns are metabolic-nutritional, hypoxic, metabolic-toxic, orthostatic-dehydration, and chronic cognitive impairment. Table 1 shows the etiologic risk patterns and clinical markers associated with each. Patients were classified as having a pattern if they exhibited at least 1 clinical marker for that pattern.
Analysis
To determine delirium resolution, the lowest NEECHAM score either at admission or during hospitalization was compared to the discharge NEECHAM score. Delirium was considered resolved if the discharge NEECHAM score was greater than or equal to 25. In patients with persistent delirium, significant improvement was defined as a change in NEECHAM category from severe (NEECHAM G 20) to mild (NEECHAM, 20Y24). Descriptive statistics were used to examine patient characteristics and delirium resolution. Fisher exact, # 2 , and t tests were used to evaluate the differences in patient characteristics, etiologic patterns, and factors between patients with and without delirium resolution.
n Results
Patient Characteristics
The characteristics of the 43 hospitalized older patients with cancer who had delirium are presented in Table 2 . The patients had a mean age of 74.6 years. Patients were almost evenly divided by sex and ethnicity. Multiple hematologic and solid organ malignancies were represented in the sample, including multiple myeloma (n = 8), leukemia (n = 3), and lymphoma (n = 1) and lung (n = 9), breast (n = 8), prostate (n = 4), colon (n = 2), liver (n = 2), and other (n = 6) malignancies. The mean APACHE II score (16.0) indicated a 30 moderately high level of illness severity. Similarly, the patients had a moderate level of functional impairment before hospitalization, as indicated by a mean IADL score of 6.8. Patients exhibited clinical markers for multiple etiologic risk patterns; the average number of etiologic risk patterns at admission was 2.6. The average length of hospital stay was 11.5 days (median = 8.0 days). Figure 2 displays the trajectories of change in delirium from hospitalization to discharge by level of severity. Forty-one of the 43 patients had delirium during their hospitalization before discharge; 2 had delirium noted at the time of discharge only. Among those with delirium during hospitalization, 18 (44%) had mild delirium, and 23 (56%) had severe delirium. At discharge, delirium was present in 30 (70%) patients: 18 had mild delirium, and 12 had severe delirium. Delirium persisted in 28 of the 41 (68%) patients who had delirium during hospitalization: 16 (57%) had mild delirium, and 12 (43%) had severe delirium.
Trajectories of Delirium Resolution
Two patients with no delirium during hospitalization had mild delirium (NEECHAM score, 20Y24) at discharge. One of the patients had a 3-point drop in NEECHAM score from 27 during hospitalization to 24 at discharge. The other had a 2-point drop in NEECHAM score from 26 to 24.
Delirium resolved in 12 of the 18 patients (67%) with mild delirium during hospitalization. The mean change in NEECHAM score among the patients with mild delirium that resolved was 5.1 points (SD, 2.47; range 2Y10). All but one of the patients had a clinically significant change of greater than 3 points in their NEECHAM scores. Six patients (33%) had persistent mild delirium. No patients with mild delirium during hospitalization had more severe delirium at discharge.
At discharge, delirium had resolved in only 1 patient with severe delirium during hospitalization. This patient's lowest NEECHAM score during hospitalization was 7, and at discharge, the NEECHAM score was 27. More than half (n = 12, 52%) with severe delirium during hospitalization had persistent severe delirium at discharge. Delirium improved from severe to mild in 10 (43%) patients. The mean change in NEECHAM score for those who improved was 6.1 points (SD, 4.38; range 1Y17). All but one of the patients had a change in NEECHAM score greater than 3 points. Table 3 compares the characteristics of patients with delirium resolution to those without delirium resolution. The 2 patients who exhibited delirium at discharge only are included in the Bno resolution[ group. Patients with delirium resolution were less functionally impaired before hospitalization (mean IADL score, 10.3 vs 5.3) and exhibited fewer etiologic risk patterns at admission (mean, 1.9 vs 2.8).
Characteristics in Patients With and Without Delirium Resolution
Patients with delirium resolution also had a shorter length of hospital stay (mean length of stay, 7.3 vs 13.3 days). Patients with mild delirium were more likely to have resolution than those with severe delirium (Figure 3 ). There were no differences between patients with delirium resolution and those without resolution with regard to sex, ethnicity, cancer type, or time of delirium onset at admission or during hospitalization.
Although delirium was more likely to resolve in patients with fewer etiologic risk patterns at admission, there were no differences in delirium resolution with regard to specific etiologic risk patterns except in those with chronic cognitive impairment. Five patients exhibited markers for chronic cognitive impairment at admission. All 5 had severe delirium at some point during hospitalization. Delirium persisted at discharge in all 5 patients with chronic cognitive impairment. It remained severe in 3 patients but improved to mild in 2.
n Discussion
Our findings highlight important aspects of delirium resolution in a sample of hospitalized older patients with cancer. Thirteen of 43 patients (30%) had delirium resolution at discharge. Another 10 (23%) had significant improvement in their delirium during hospitalization from severe to mild. Nevertheless, delirium persisted at discharge in a significant majority of patients (70%). Previous studies have demonstrated the potential reversibility or improvement in delirium among patients with cancer, even in those with advanced cancer near the end of life.
14,18Y20,22,23,26 In Ljubisavljevic and Kelly's study, 14 the incidence of delirium was 18% in a sample of 113 relatively young cancer patients (mean age = 53 years). Delirium reversed in all cases in patients who survived. The average duration of delirium episodes was 2.1 days. The authors suggested that early recognition and intervention may have limited the duration of delirium episodes and promoted reversibility. The younger age of patients in their sample may also have influenced delirium resolution. Lawlor and colleagues 19 found that delirium reversed in 49% of episodes in 71 patients with advanced cancer. Reversibility of repeated delirium episodes was significantly less than the reversibility of first episodes.
Studies also have shown that significant symptom improvement can occur in patients with advanced cancer, in some cases even without specific intervention. 18, 20, 26 Bruera and colleagues 18 found that delirium improved in 22 (33%) episodesVspontaneously in 10 episodes and as a result of treatment in 12 episodes. Similarly, Pereira and colleagues 26 found that delirium improved in 29% of patients with advanced cancer before death or discharge from a palliative care unit. In Gagnon and colleagues' study, 20 delirium was treated with various interventions, such as adding a neuroleptic drug or opioid reduction or switching to another opioid. Half of the patients with delirium experienced clinically significant symptom improvement. Notably, 6 patients who improved remained asymptomatic in the last 24 hours of life.
Despite the potential reversibility of delirium in hospitalized patients with cancer, our findings add to the growing literature, suggesting that delirium is not a transient disorder. A significant majority (70%) of the older patients with cancer who had delirium during hospitalization had persistent delirium at discharge. These findings are consistent with other studies showing that a substantial number of hospitalized older patients are discharged with delirium. 2Y5 In a sample of medical inpatients aged 70 years or older, Adamis and colleagues 2 found that only 14 of 33 patients (42%) with delirium recovered during their hospitalization. The remaining 19 (58%) patients were positive for delirium at their last assessment before death or discharge.
Factors Associated With Delirium Resolution
Identifying factors associated with delirium resolution and persistence in older patients with cancer is an important area of investigation. The identification of these factors will provide targets for prevention and intervention. Research in this area may also enhance our understanding of the relationships between delirium and associated outcomes such as long-term cognitive impairment, functional decline, and increased mortality.
Patients with delirium resolution were less functionally impaired before hospital admission compared to those without resolution. Similarly, Inouye and colleagues 36 found that functional impairment before hospitalization was an independent risk factor for delirium at discharge. Patients with functional impairment were 1.7 times (95% confidence interval, 1.2Y3.0) more likely to have delirium at discharge than those without functional impairment. The severity of delirium influenced its resolution. Similar to findings from Adamis and Colleague's study, 2 mild cases of delirium were more likely to resolve than severe cases. Although patients with severe delirium were more likely to have persistent delirium at discharge, it is important to note that in 10 (23%) patients, delirium improved from severe during hospitalization to mild at discharge. Others have found that although delirium may not resolve completely, significant symptom improvement is possible. 18, 20, 26 Early recognition of mild delirium is important because it may be more amenable to treatment. Furthermore, the identification and treatment of mild delirium may ameliorate the development of more severe delirium.
In our study, delirium was more likely to resolve in patients with fewer etiologic risk patterns; however, specific risk patterns, except for chronic cognitive impairment, were not associated with delirium resolution. The effect of different combinations of etiologic patterns was not examined but may have influenced delirium resolution. In a recent study, Doriath and colleagues 22 found that delirium was reversible in 34% of patients with cancer, and delirium was more likely to reverse in patients with toxic and metabolic causes compared to those with structural brain lesions. Studies in patients with advanced cancer 19, 25 also have examined the relationships between delirium etiology and reversibility. In Lawlor and colleagues' study, 19 opioid analgesics and other psychoactive medications were independently associated with delirium reversal. Dehydration was also significantly associated with delirium reversibility at the univariate level, but its association was not independent in the multivariate analysis. Hypoxic encephalopathy resulting from pulmonary cancer or respiratory tract infection and metabolic factors were associated with the nonreversibility of delirium in the univariate analysis. In the multivariate analysis, only hypoxic encephalopathy was retained as a factor. In addition, nonYrespiratory tract infection emerged as a significant independent factor associated with nonreversibility of delirium. Morita and colleagues 25 found that recovery often occurred in delirium associated with medications and hypercalcemia, and recovery was unlikely in delirium caused by hepatic failure, dehydration, hypoxia, and disseminated intravascular coagulopathy. Other researchers 37Y39 have found that delirium resolved in hypoxic patients who were treated with supplemental oxygen.
Our findings highlight the vulnerability of patients with cancer who also have underlying cognitive impairment. All patients with chronic cognitive impairment had severe delirium at some point during hospitalization. Furthermore, all patients with chronic cognitive impairment had persistent delirium at discharge. Inouye and colleagues 36 also found that cognitive impairment (ie, dementia) was a significant risk factor for delirium at discharge. Similarly, Adamis and colleagues 2 noted that baseline cognitive function was associated with recovery from delirium. Patients with better cognitive function at admission were more likely to recover from delirium during hospitalization. In our study, delirium improved from severe to mild in 2 patients with chronic cognitive impairment.
Prolonged Hospitalization
Patients with delirium resolution had a shorter length of hospital stay compared to those who had persistent delirium. The impact of prolonged hospitalization in older cancer patients with persistent delirium is an important consideration. Older adults often experience a decline in physical function during hospitalization. 40 In this study, we did not examine physical functioning at discharge, but it is likely that the older patients with cancer who had persistent delirium were more functionally impaired. The combination of impaired cognitive and physical functioning in older patients with cancer adds substantially to a caregiver's burden and distress.
Implications for Clinical Practice and Research
The results of this study have significant implications for clinical practice and future research. The time surrounding hospital discharge is an important and vulnerable transition period for hospitalized older patients with cancer and their caregivers. Patients with delirium at discharge are a high-risk group. 3, 36, 41 The persistence of delirium at discharge affects posthospital care and recovery regardless of the settingVat home or in skilled nursing and other residential facilities.
Delirium is distressing for patients and their family caregivers.
42Y44 Delirium impairs patient-family communication and negatively affects treatment decision making and adherence. Patients with delirium also may not be able to report other physical and psychological symptoms. In addition, caregivers may experience increased burden because patients with delirium require increased assistance with care and close monitoring to prevent injury. Patients with cognitive impairment (ie, dementia, delirium, or both) during hospitalization and their family caregivers often have significant unmet needs in the weeks after hospital discharge. 45 Additional research is necessary to better understand the needs of patients with persistent delirium and their family caregivers. Educational and supportive interventions to address the identified needs should be developed.
In hospitalized older patients, delirium at discharge is a poor prognostic factor. Patients with delirium at discharge are at greater risk for nursing home placement and death during a 1-year follow-up period. 41 Persistent delirium at admission to postYacute care settings has been associated with rehospitalization, prolonged institutionalization, poor functional recovery, and death. 8, 9 Little is known about outcomes associated with persistent delirium in cancer patients. Hospitalized older patients with cancer who have delirium at discharge are at risk for adverse outcomes similar to those of hospitalized older patients with persistent delirium. They may be at even greater risk because persistent delirium may affect their subsequent cancer treatment. For example, their cancer treatment may be delayed or discontinued, or they may need to receive reduced chemotherapy doses while they are recuperating. Research is needed to examine outcomes of delirium, specifically in hospitalized older patients with cancer.
Patients with persistent delirium require ongoing management, monitoring, and follow-up after hospital discharge. Patients with persistent delirium need to be identified before discharge. Moreover, persistent delirium needs to be reported to providers (eg, physicians, nurses, and nursing assistants) in the posthospital care setting. van Zyl and Davidson 46 found that even when delirium is diagnosed and treated, it is not consistently documented in hospital discharge summaries, the primary communication link between hospital providers and providers in other settings. Therefore, it may not be communicated to outside providers.
Although patients with delirium are more likely to be discharged to institutional settings, we do not know where and how to best care for patients with persistent delirium after discharge. An important area for future research is to determine the best place to care for patients with persistent delirium after discharge, as well as to identify the most appropriate care for these patients. The goals of care need to focus on facilitating improvement and preventing further decline. Education focusing on delirium assessment and management is needed for professional caregivers in postacute care settings (eg, rehabilitation, home, long-term care) and for family caregivers.
n Strengths and Limitations
To our knowledge, this study is one of the first to examine delirium resolution and associated factors in a sample of hospitalized older patients with cancer. A strength of the study was the daily assessment of delirium using an instrument that measures delirium severity and allows monitoring of changes in delirium over time.
The study also has several limitations. A primary limitation is the small, heterogeneous sample of older patients with cancer. The patients had a variety of cancer diagnoses, their cancers were at different stages, and they were receiving different cancer treatments. The reason for hospital admission also varied. Some patients were admitted to the hospital for cancer treatment, others were admitted for complications associated with their cancer or cancer treatment, and others were admitted for acute medical conditions unrelated to their cancer. The sample included prevalent and incident cases of delirium. In our study, the time of onset for delirium did not affect delirium resolution. Gagnon and colleagues 20 found that symptom improvement occurred less often in patients who were delirious at admission compared to those who developed delirium after admission. Delirium etiology and prognosis may differ between prevalent and incident cases. 41 In this study, we used a conservative definition for delirium improvementVa change in NEECHAM category from severe to mild. It is likely that some patients had a clinically significant change in NEECHAM score within a severity category, but we did not examine changes within categories. Finally, we did not examine specific strategies to treat and manage delirium during hospitalization. For example, it was not known whether patients received psychotropic medications or other supportive interventions.
n Conclusion
The management of delirium in hospitalized older patients with cancer needs to focus on prevention and early recognition of symptoms and their reversibility. Early recognition and intensive treatment are paramount. Interventions targeted at common delirium risk factors in cancer patientsV malnutrition, dehydration, anemia, electrolyte imbalance, pain, uncontrolled physical and psychological symptoms, and polypharmacy including opioids and other psychoactive medicationsVmay prevent the development of delirium. If delirium develops, initial treatment should aim to identify and correct treatable causes. Supportive interventions are needed to mitigate further complications. The identification of patients at risk, the recognition of early manifestations, and interventions targeted at multiple risk factors and etiologies may prevent delirium or result in its improvement and resolution. Additional studies are needed to develop and test interventions to prevent and better manage delirium in hospitalized older patients with cancer.
Although delirium in hospitalized older patients with cancer is potentially reversible, we found that a significant number of hospitalized older patients with cancer had delirium at the time of hospital discharge. As hospital length of stay decreases, it is likely that even more patients will be discharged before delirium resolves. Therefore, the clinical management of delirium and delirium research can no longer be confined solely to the hospital setting. Hospitalized older patients with cancer who have delirium at discharge represent a high-risk group. Patients with unresolved delirium need to be identified before discharge because they require monitoring and close follow-up. Strategies to improve discharge planning and care coordination for patients with persistent delirium are needed. Efforts should be made to promote continuity of care and enhance communication between healthcare providers in the hospital and postdischarge care settings. Family members caring for patients with persistent delirium need education and support. Patients with persistent delirium require continued supportive care to promote delirium resolution and prevent worsening of delirium or other complications.
